|
Volumn 16, Issue 6, 1999, Pages 649-660
|
Managing pharmaceutical expenditure while increasing access: The Pharmaceutical Management Agency (PHARMAC) experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
STATIN;
COST UTILITY ANALYSIS;
DRUG COST;
DRUG INDUSTRY;
FINANCIAL MANAGEMENT;
GOVERNMENT;
HEALTH CARE COST;
HEALTH CARE MANAGEMENT;
HEALTH CARE POLICY;
NEW ZEALAND;
PRIORITY JOURNAL;
REVIEW;
|
EID: 0033429890
PISSN: 11707690
EISSN: None
Source Type: Journal
DOI: 10.2165/00019053-199916060-00004 Document Type: Review |
Times cited : (50)
|
References (10)
|